181 related articles for article (PubMed ID: 17719143)
21. Activity of the serotonergic system during isoflurane anesthesia.
Mukaida K; Shichino T; Koyanagi S; Himukashi S; Fukuda K
Anesth Analg; 2007 Apr; 104(4):836-9. PubMed ID: 17377090
[TBL] [Abstract][Full Text] [Related]
22. Modulation of dopamine release by striatal 5-HT2C receptors.
Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
[TBL] [Abstract][Full Text] [Related]
23. Effects of volatile anesthetics, thiopental, and ketamine on spontaneous and depolarization-evoked dopamine release from striatal synaptosomes in the rat.
Mantz J; Varlet C; Lecharny JB; Henzel D; Lenot P; Desmonts JM
Anesthesiology; 1994 Feb; 80(2):352-63. PubMed ID: 8311317
[TBL] [Abstract][Full Text] [Related]
24. Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum.
Porras G; De Deurwaerdère P; Moison D; Spampinato U
Eur J Neurosci; 2003 Feb; 17(4):771-81. PubMed ID: 12603267
[TBL] [Abstract][Full Text] [Related]
25. MDMA induced dopamine release in vivo: role of endogenous serotonin.
Koch S; Galloway MP
J Neural Transm (Vienna); 1997; 104(2-3):135-46. PubMed ID: 9203077
[TBL] [Abstract][Full Text] [Related]
26. Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram.
Pozzi L; Invernizzi R; Garavaglia C; Samanin R
J Neurochem; 1999 Sep; 73(3):1051-7. PubMed ID: 10461894
[TBL] [Abstract][Full Text] [Related]
27. The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.
Lucas G; De Deurwaerdère P; Caccia S; Umberto Spampinato
Neuropharmacology; 2000 Apr; 39(6):1053-63. PubMed ID: 10727716
[TBL] [Abstract][Full Text] [Related]
28. [The effect of halothane anesthesia on dopamine release induced by apomorphine or haloperidol--an in vivo microdialysis study in rats striatum].
Adachi Y; Wada H; Higuchi H; Watanabe K; Satoh T
Masui; 2001 Oct; 50(10):1089-95. PubMed ID: 11712340
[TBL] [Abstract][Full Text] [Related]
29. Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo.
Di Matteo V; Cacchio M; Di Giulio C; Di Giovanni G; Esposito E
Pharmacol Biochem Behav; 2002 Apr; 71(4):607-13. PubMed ID: 11888552
[TBL] [Abstract][Full Text] [Related]
30. Effect of isoflurane and halothane on in vivo ischemia-induced dopamine release in the corpus striatum of the rat. A study using cerebral microdialysis.
Koorn R; Kahn RA; Brannan TS; Martinez-Tica J; Weinberger J; Reich DL
Anesthesiology; 1993 Oct; 79(4):827-35. PubMed ID: 8214763
[TBL] [Abstract][Full Text] [Related]
31. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum.
Perry KW; Fuller RW
Life Sci; 1992; 50(22):1683-90. PubMed ID: 1375306
[TBL] [Abstract][Full Text] [Related]
32. 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.
Rollema H; Lu Y; Schmidt AW; Sprouse JS; Zorn SH
Biol Psychiatry; 2000 Aug; 48(3):229-37. PubMed ID: 10924666
[TBL] [Abstract][Full Text] [Related]
33. Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions.
Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
Neuroscience; 1999; 93(4):1251-62. PubMed ID: 10501449
[TBL] [Abstract][Full Text] [Related]
34. Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis.
Benloucif S; Galloway MP
Eur J Pharmacol; 1991 Jul; 200(1):1-8. PubMed ID: 1769366
[TBL] [Abstract][Full Text] [Related]
35. Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat.
Bonhomme N; De Deurwaèrdere P; Le Moal M; Spampinato U
Neuropharmacology; 1995 Mar; 34(3):269-79. PubMed ID: 7543190
[TBL] [Abstract][Full Text] [Related]
36. Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats.
Li SX; Perry KW; Wong DT
Neuropharmacology; 2002 Feb; 42(2):181-90. PubMed ID: 11804614
[TBL] [Abstract][Full Text] [Related]
37. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.
Navailles S; De Deurwaerdère P; Porras G; Spampinato U
Neuropsychopharmacology; 2004 Feb; 29(2):319-26. PubMed ID: 14560323
[TBL] [Abstract][Full Text] [Related]
38. [The effect of normobaric oxygen inhalation and halothane anesthesia on the level of interstitial striatal dopamine of rats using in vivo microdialysis study].
Adachi Y; Satomoto M; Higuchi H; Watanabe K; Satoh T
Masui; 2002 Mar; 51(3):240-6. PubMed ID: 11925885
[TBL] [Abstract][Full Text] [Related]
39. Functional regulation by dopamine receptors of serotonin release from the rat hippocampus: in vivo microdialysis study.
Matsumoto M; Yoshioka M; Togashi H; Ikeda T; Saito H
Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):621-9. PubMed ID: 8738295
[TBL] [Abstract][Full Text] [Related]
40. Endogenous serotonin stimulates striatal dopamine release in conscious rats.
Yadid G; Pacak K; Kopin IJ; Goldstein DS
J Pharmacol Exp Ther; 1994 Sep; 270(3):1158-65. PubMed ID: 7932166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
